Insmed, Inc. (INSM) CEO Will Lewis on Q2 2019 Results - Earnings Call Transcript [Seeking Alpha]
Insmed, Inc. (INSM)
Last insmed, inc. earnings: 4/30 07:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
investor.insmed.com
Company Research
Source: Seeking Alpha
Insmed, Inc. (INSM) CEO Will Lewis on Q2 2019 Results - Earnings Call Transcript Insmed, Inc. (NASDAQ: INSM Company Participants Blaine Davis - Head of Investor Relations Will Lewis - Chairman and Chief Executive Officer Roger Adsett - Chief Commercial Officer John Goll - Chief Accounting Officer Conference Call Participants Martin Auster - Credit Suisse Matthew Harrison - Morgan Stanley Adam Walsh - Stifel Financial Corp Joseph Schwartz - SVB Leerink Josh Schimmer - Evercore ISI Liisa Bayko - JMP Securities Operator Good day, ladies and gentlemen, and welcome to the Insmed conference call to discuss company second-quarter financial results. [Operator instructions] As a reminder, this conference call is being recorded. I would now like to introduce your host for today's conference, Mr. Blaine Davis, head of investor relations. You may begin, sir. Thanks, Nancy. Good morning, everyone, and welcome to today's conference call to discuss our second-quarter financial results for 2019. Befo
Show less
Read more
Impact Snapshot
Event Time:
INSM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
INSM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
INSM alerts
High impacting Insmed, Inc. news events
Weekly update
A roundup of the hottest topics
INSM
News
- Artisan Mid Cap Fund Q4 2025 Performance Discussion And Portfolio Activity [Seeking Alpha]Seeking Alpha
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insmed Incorporated - INSMPR Newswire
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insmed Incorporated - INSMGlobeNewswire
- Insmed CEO Will Lewis talks its rare disease drug pipeline [CNBC]CNBC
- Insmed (NASDAQ:INSM) was given a new $205.00 price target on by analysts at Truist Financial Corporation.MarketBeat
INSM
Earnings
- 10/30/25 - Miss
INSM
Sec Filings
- 1/13/26 - Form 4
- 1/13/26 - Form 4
- 1/12/26 - Form 144
- INSM's page on the SEC website